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Feline Viral Upper Respiratory
Diseases
Barbara J. Hill, BS, DVM*
Susan O'Brien, DVM* *
Infectious upper respiratory disease is the
most common and probably the most devas-
tating respiratory syndrome recognized in
cats. 1 Three infectious diseases are responsi-
ble: feline viral rhinotracheitis (FVR), feline
calicivirus infection, and feline pneumonitis
(Chlamydia psittaci). Feline Viral Rhinotra-
cheitis and caliciviral infection account for the
majority of clinical cases and will be reviewed
here. These two viral diseases comprise 80 to
90 % of infectious upper respiratory disease in
domestic cats and are isolated in approxi-
mately equal frequency. Both affect the feline
respiratory tract and conjunctival membranes
and cause a variety of clinical signs in infected
cats. Both FVR and feline calicivirus have a
widespread distribution throughout the
world; serological studies have shown specific
antibodies present in 80 % or greater of adult
cat populations. 2
The Agents
The etiologic agent of FVR is feline herpes-
virus, which causes characteristic intranuclear
inclusion bodies in infected cells. The virus is
fragile and is susceptible to heat, acid and
common disinfectants (e. g. hypochlorite or
quaternary ammonium compounds).4 Feline
herpesvirus appears to be highly species-spe-
cific for the domestic cat.
Feline calicivirus is composed of a number
of serologic variants, or strains. It is slightly
hardier than FVR, but is susceptible to the
same disinfectants as FVR.
Pathogenesis and Lesions
The mucosal surfaces of the upper respira-
tory tract and conjunctiva are predilection
sites for feline herpesvirus, and viral replica-
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tion takes place in the mucosa of the nose,
turbinates and conjunctiva. The principal le-
sions in FVR are necrosis of epithelium and
associated purulent inflamn1ation. 5 The sub-
sequent exudates may cause dyspnea and
paroxysmal coughing and sneezing. Lesions
do not usually extend to the bronchi, bronchi-
oles, or alveoli. Intranuclear inclusion bodies
can be demonstrated in n1ucosal epithelium
for up to 7 days after infection.
Feline calicivirus strains vary in their viru-
lence. Viral replication occurs in the oral and
respiratory mucosa and the conjunctiva. For-
merly, it was thought that the virus affected
mainly the upper respiratory tract, as in
FVR, but it has been more recently demon-
strated that while calicivirus does affect the
conjunctiva and upper airways, the lung is
also an important target for the more virulent
strains.
Transmission
Transmission of both viruses is most com-
monly by direct contact with infectious oral,
nasal, or ocular secretions, or by contact with
contaminated fomites. Aerosol transmission is
uncommon and appears to be much less im-
portant in the spread of the disease than ear-
lier postulated. 6 ,7 Route of infection may be
intranasal, oral, or conjunctival.
Clinical Syndromes
Cats of any age can be affected by viral res-
piratory disease, but the morbidity and mor-
tality is highest in young cats and kittens.
Anorexia, fever and depression are common
with both viral infections. Feline viral rhino-
tracheitis produces a characteristic syndrome
in susceptible cats. After a 2 to 8-day incuba-
tion period, early signs include hypersaliva-
tion, sneezing, and clear, serous, ocular and
nasal discharges. As the disease progresses,
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conjunctIvItIS and coughing may develop.
Ocular and nasal secretions may become mu-
copurulent, especially with secondary bacter-
ial invasion. The ocular manifestations of fe-
line herpesvirus primarily involve the con-
junctiva, but ulcerative keratitis may de-
velop.8 A leukocytosis is generally present
throughout the course of the disease. The ma-
jority of clinical signs have usually resolved
within 10 to 20 days, but some animals may
be left with chronic sequelae such as persistant
conjunctivitis or rhinitis. The recurrent clini-
cal signs seen in these chronically affected cats
is most often due to secondary bacterial inva-
sion of mucosal surfaces originally damaged
by the virus. 4
In general, the disease produced by feline
calicivirus is similar to but rnilder than FVR,
although the range of clinical signs varies
greatly among the various strains of the virus.
The majority of strains, after a 2 to 10-day
incubation period, produce a mild upper res-
piratory disease with ocular and nasal dis-
charge and ulceration of the tongue, hard pa-
late, and nostrils. In some cases mouth
ulcerations n1ay be the only clinical sign of
infection. The more virulent strains of cali-
civirus may produce a primary interstitial
pneumonia with resulting dyspnea.
Involvement of systems other than the res-
piratory tract can occur with FVR. Feline
viral rhinotracheitis has been associated with
central nervous system dysfunction and liver
disease, but only in very young, old, or im~
munosuppressed animals. 13 Feline herpes-
virus has also been associated with ulcerations
of the skin. 9
The Carrier State
As stated previously, both feline respiratory
viruses are relatively fragile, and thus they
must rely for their continued survival on their
ability to persist in the cat. In both FVR and
feline calicivirus infections most of the clinical
signs regress over a period of 10 -12 days. Af-
ter this time any animal which remains per-
sistently infected with the virus is termed a
"carrier." The carrier animal may be asympto-
matic or show chronic symptoms of the dis-
ease. The carrier state of FVR is character-
ized by latent periods with only intermittent
episodes of virus shedding. During such epi-
sodes the carrier is highly infectious to other
cats. 4 Carriers may shed spontaneously or
subsequent to stresses such as corticosteroid
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therapy, general anesthesia, cat shows, etc.
An estimate of up to 80 % of FVR-recovered
cats remain carriers for a variable period of
time. 4 Cats may spontaneously clear the virus
after months or years, but some animals re-
main carriers for life.
Unlike FVR, carrier cats of feline cali-
civirus excrete virus more or less continuously
from the orophrynx. Such animals are there-
fore a constant hazard to susceptible cats. In a
survey of 1500 clinically healthy cats, sampled
with a single oro-pharyngeal swab, feline cali-
civirus was found to be widespread; 8 % of
single household pets, 24 % of cats attending
cat shows and 41.5% of cats in institutional
colonies were found to be excreting the
virus. 12
Diagnosis
Differentiation of FVR and feline cali-
civirus infection on the basis of clinical signs
alone is difficult and generally not recom-
mended. Clinical differentiation is possible
based on the principle that while some mani-
festations (e. g. fever, depression , anorexia)
are common to both diseases, others signs are
more frequently associated with one infection
or the other. Rhinitis and conjunctivitis with
serous to mucopurulent discharges, keratitis,
blepharospasm, sneezing, coughing, hypersa-
livation and oral respiration are signs most
suggestive of FVR, while ulcers of the tongue,
hard palate and nostrils, occasionally asso-
ciated with signs of pneumonia are more con-
sistent with feline calicivirus. Unfortunately,
differentiation of the two viral infections is not
always as simple as descriptions suggest, due
to overlap and variation in clinical signs and
severity of infection and complications with
secondary infections. Therefore, definitive
diagnosis is best made serologically or by
virus isolation. However, because treatment
of both viral diseases is symptomatic in the
majority of clinical cases, etiologic diagnosis
of upper respiratory viral disease in cats is
generally not necessary or economically war-
ranted.
Treatment
The intensity of treatment of viral respira-
tory disease is dependent on the severity of
clinical signs. In some cases clinical manifes-
tations are so mild and the cat so relatively
unaffected that no treatment is required. 10 In
the case of the more severely affected cat,
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however, prompt and vigorous therapy is nec-
essary. Therapy is for the most part sympto-
matic and supportive. Good nursing care is
extremely imporant in the treatment of these
cats, as respiratory arrest secondary to airway
obstruction and/or pneumonia, dehydration,
and malnutrition are the usual causes of
death. 1
Affected cats should be kept in a clean,
warm, well-ventilated environment and dis-
charges from the eyes and nose should be
cleaned away frequently. Antibiotics should
be given for a minimum of 7 days to help
control secondary bacterial infection. Good
choices include ampicillin, hetacin K, or
chloramphenicol. In more severely affected
animals in which dehydration becomes a
problem, fluid therapy may be necessary.
Subcutaneous lactated Ringer's solution or
2112 % dextrose diluted 50: 50 with saline is of-
ten adequate, but some cats may require in-
travenous fluids.
Cats should be encouraged to eat by of-
fering strongly flavored odorous foods (e. g.
sardines , tuna). Soft or semi-liquid foods,
such as strained-meat baby food may be more
palatable to those animals in which painful
oral ulceration has developed. The placement
of a pharyngostomy tube may become neces-
sary in cats that have been anorectic for
several days. This conveniently allows re-
placement of both calories and fluids with a
minimum of stress to the cat and is far supe-
rior to repeated attempts at force-feeding or
stomach tubing.
Warm humidification or nebulization is of-
ten beneficial in relieving airway obstruction.
Acetylcysteine 20 % diluted 1:8 with saline
may be added to the nebulization formula as a
mucolytic if secretions are viscous and inspis-
sated. Additionally, 0.25 % phenylephrine or
0.025% oxymethazoline will provide tem-
porary relief of nasal congestion when used
judiciously. 11
Vitamin therapy including vitamins A
(10,000 IU daily) and B-complex are indi-
cated in the severely ill cat. Vitamin C may
also be given intravenously at a rate of 1 gram
daily.
Ocular therapy is critical to avoid corneal
damage and panophthalmitis, especially in
FVR. Broad spectrum antibiotic ophthalmic
ointment should be started promptly, and cor-
ticosteroids should be avoided due to the po-
tential for corneal ulceration to develop
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during the course of the infection.
The chronic rhinitis and/or sinusitis that is
sometimes a sequelae to viral upper respira-
tory disease presents a therapeutic challenge
for the veterinarian. The more chronic the
condition becomes, the more unlikely it is that
conservative therapy will help. 10 The majority
of these animals are suffering from persistent
or recurrent secondary bacterial infections,
and prolonged (2 - 3 week) antibiotic therapy
following culture and sensitivity may be bene-
ficial. Unfortunately, the improvement seen is
often temporary and ultimately surgical pro-
cedures, including trephining the frontal
sinus, may be necessary. Some chronically af-
fected cats show improvement when housed
outside. 4
Prevention and Control
The prevention and control of feline viral
upper respiratory disease has two con1po-
nents: immunoprophylaxis via a vaccination
program, and management practices aimed at
preventing transmission of the viruses. The
development of effective vaccines against
FVR and feline calicivirus is potentially the
most effective means of controlling the dis-
eases. 10 Inactivated and MLV parenteral vac-
cines and MLV intranasal vaccines are avail-
able. The parenteral vaccines are also
available in combination with feline pan-
leukopenia MLV or inactivated vaccine, and
have been extensively tested for safety and ef-
ficacy.13.14 The parenteral vaccines evoke ade-
quate serum antibodies. The intranasal vac-
cines also appear to be safe and efficacious,
but do show an increased number of minor
side reactions, particularly transient sneezing
1 to 16 days post-vaccination. Less common
reactions include a raw nose, transient anore-
xia and lacrimation. Cats recover from these
reactions uneventfully.17 A single dose of in-
tranasal vaccine produces significant protec-
tion for at least one year. Kittens may be vac-
cinated at 8 to 10 weeks of age with yearly
revaccination.
Proper management practices can aid
greatly in the prevention of transmission of
feline viral respiratory disease. The greatest
management challenge exists in veterinary
hospitals and catteries. Within a veterinary
facility adequate ventilation is probably the
most effective means of disease prevention.
Twelve air exchanges per hour are desirable. 10
Fomite transmission can be minimized by use
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of disposable litter trays and feeding dishes
and by thorough cleaning of cages with ap-
proved viricidal disinfectants. People han-
dling potentially infectious cats should change
outer smocks and wash their hands thor-
oughly afterwards.
In the cattery, in addition to vaccination,
isolation becomes an important aspect of dis-
ease control. 10 Animals entering the colony
following purchase, a cat show, or breeding
should be quarantined for three weeks. 4 Ani-
mals in the colony can be screened virologi-
cally and serologically in an attempt to iden-
tify carriers, although because of the high
prevalence of the diseases, elimination of car-
riers is seldom practical. Kittens may be
weaned early (four to five weeks of age) before
lllaternal antibody levels have declined and
vaccinated immediately to maximize protec-
tion.
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